Published in Br J Dermatol on February 01, 1993
Development of a practical guide for the early recognition for malignant melanoma of the foot and nail unit. J Foot Ankle Res (2010) 0.81
Malignant melanoma of sun-protected sites: a review of clinical, histological, and molecular features. Lab Invest (2017) 0.80
Use of imiquimod for residual acral melanoma. BMJ Case Rep (2014) 0.75
Malignant melanoma misdiagnosed as diabetic foot ulcer: A case report. Medicine (Baltimore) (2017) 0.75
Is evidence for homoeopathy reproducible? Lancet (1994) 6.55
Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ (2000) 4.10
Personal risk-factor chart for cutaneous melanoma. Lancet (1989) 2.65
Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet (1992) 2.31
Umbilical cord clamping and preterm infants: a randomised trial. BMJ (1993) 2.17
Systemic complement activation in psoriasis vulgaris. Clin Exp Dermatol (1996) 1.94
Tanning with ultraviolet A sunbeds. BMJ (1990) 1.93
Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease. Br Med J (1972) 1.84
The number and distribution of benign pigmented moles (melanocytic naevi) in a healthy British population. Br J Dermatol (1985) 1.75
The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Psychol Med (1983) 1.59
Compliance with inhaled asthma medication in preschool children. Thorax (1995) 1.58
A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychol Med (1978) 1.54
Juvenile plantar dermatosis: a new entity?. Clin Exp Dermatol (1976) 1.51
The effects of a 12-week group exercise programme on physiological and psychological variables and function in overweight women. Public Health (2004) 1.51
Mental hospitals and community care: discussion paper. J R Soc Med (1986) 1.47
Assessment of an anti-T-cell receptor variable region antibody panel in cutaneous T-cell lymphoma. Br J Dermatol (1994) 1.39
The suitability of SunCheck patches and Tanscan cards for monitoring the sunburning effectiveness of sunlight. Br J Dermatol (1993) 1.38
Health and the ozone layer. BMJ (1988) 1.37
UVA-induced melanocytic lesions. Br J Dermatol (1987) 1.35
Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet (1984) 1.34
An inner city preschool visual screening programme: long-term visual results. Br J Ophthalmol (1998) 1.21
Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol (1984) 1.14
Caution in locating the gene(s) for affective disorder. Psychol Med (1989) 1.11
Site-specific melanocytic naevus counts as predictors of whole body naevi. Br J Dermatol (1988) 1.09
A comparison of the anthropometric, strength, endurance and flexibility characteristics of female elite and recreational climbers and non-climbers. J Sports Sci (2001) 1.06
Assessment of prognosis in patients with malignant melanoma. Lancet (1972) 1.05
Assessment of a contact-plate sampling technique and subsequent quantitative bacterial studies in atopic dermatitis. Br J Dermatol (1990) 1.04
Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. Br J Dermatol (1994) 1.04
Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study. J Natl Cancer Inst (2010) 1.04
Alzheimer's disease in a mother and identical twin sons. Psychol Med (1979) 1.03
Clinical accuracy of the diagnosis of cutaneous malignant melanoma. Br J Dermatol (1998) 1.03
Waiting times for and attendance at paediatric ophthalmology outpatient appointments. BMJ (1996) 1.00
Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliat Med (1997) 0.99
Cell-mediated immunity in patients with malignant melanoma. Br J Dermatol (1972) 0.99
Bovine acute phase response following turpentine injection. Res Vet Sci (1988) 0.99
Loss of beta2 microglobulin from the cell surface of cutaneous malignant and premalignant lesions. Br J Dermatol (1981) 0.98
Sensitization to tumour-associated antigens in human breast carcinoma. Int J Cancer (1974) 0.97
Sickness scoring and response to treatment as predictors of outcome from critical illness. Intensive Care Med (1988) 0.97
A clinico-genetic study of psychiatric disorder in Huntington's chorea. Psychol Med (1993) 0.97
Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86, and their subsequent validation. Br J Cancer (1995) 0.97
Seven-point checklist for melanoma. Clin Exp Dermatol (1991) 0.96
Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study. Br J Cancer (2001) 0.93
The spectrum of mutations in erythrokeratodermias--novel and de novo mutations in GJB3. Hum Genet (2000) 0.93
The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine. Psychol Med (1978) 0.93
False positive ECG reports of anterior myocardial infarction in women. J Electrocardiol (2000) 0.92
Is it possible to predict the blood volume of a sick preterm infant? Arch Dis Child Fetal Neonatal Ed (2004) 0.92
Effects of an energy and micronutrient supplement on anthropometry in undernourished children in Indonesia. Eur J Clin Nutr (2000) 0.92
An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol (1998) 0.92
Oral disease in terminally ill cancer patients with xerostomia. Oral Oncol (1998) 0.92
Severe reaction to diphosphonate: implications for treatment of Paget's disease. BMJ (1988) 0.89
Leukocyte migration inhibition by cancer patients' sera. Int J Cancer (1976) 0.89
The effect of sex, marriage and age at first admission on the hospitalization of schizophrenics during 2 years following discharge. Psychol Med (1979) 0.89
Serum anti-tumour antibodies and auto-antibodies in vitiligo. Br J Dermatol (1975) 0.88
The prescription of isotretinoin to women: is every precaution taken? Br J Dermatol (1998) 0.88
A new 12-lead pediatric ECG interpretation program. J Electrocardiol (1990) 0.87
Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol (1996) 0.87
Tioconazole nail solution--an open study of its efficacy in onychomycosis. Clin Exp Dermatol (1985) 0.87
An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow. Br J Dermatol (1997) 0.86
The value of the coefficient of variation in assessing repeat variation in ECG measurements. Eur Heart J (1998) 0.86
Letter: Formalin-fixed tumour cells in the leukocyte migration test. Lancet (1973) 0.86
Lupus erythematosus in association with finger-clubbing. Br J Dermatol (1973) 0.85
Measured bronchodilator use in preschool children with asthma. BMJ (1995) 0.85
Pustular psoriasis in association with renal amyloidosis. Br J Dermatol (1974) 0.85
An assessment of the diagnostic value of the monoclonal antibodies Leu 8, OKT9, OKT10 and Ki67 in cutaneous lymphocytic infiltrates. Br J Dermatol (1986) 0.85
The effect of treatment with 13-cis-retinoic acid on the metabolic burst of peripheral blood neutrophils from patients with acne. Br J Dermatol (1991) 0.85
Multiple primary melanoma: risk factors and prognostic implications. BMJ (1994) 0.84
Natural-killer-cell activity in atopic dermatitis. Clin Allergy (1984) 0.83
The effect of nebulised pentamidine on the concentration of intra-oral Candida albicans in HIV-infected patients. J Med Microbiol (1994) 0.83
The relationship between immunological parameters and response to therapy in resistant oral candidosis. Br J Dermatol (1978) 0.83
Screening for the small-for-dates fetus: a two-stage ultrasonic examination schedule. Br Med J (1980) 0.83
Formalinized tumour cells in the leucocyte migration inhibition test. Clin Exp Immunol (1975) 0.83
A comparison of mobility assessments in a geriatric day hospital. Clin Rehabil (2001) 0.82
Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol (1992) 0.82
Probes in Huntington's chorea. Nature (1986) 0.82
Plasma zinc in psoriatic in-patients treated with local zinc applications. Br J Dermatol (1980) 0.81
Metabolism, anticholinergic effects, and therapeutic outcome of desmethylimipramine in depressive illness. Psychol Med (1972) 0.81
Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment. Yale J Biol Med (1973) 0.80
Indirect leukocyte migration assay in patients with malignant melanoma. Int J Cancer (1979) 0.80
The use of a double-label immunoperoxidase monoclonal antibody technique in the investigation of patients with mycosis fungoides. Br J Dermatol (1982) 0.80
First time marathoners and distance training. Br J Sports Med (1984) 0.80
A multicentre phase II trial of vindesine in malignant melanoma. Eur J Cancer Clin Oncol (1982) 0.80
Lionel Penrose, F.R.S. (1898-1972) and eugenics: part one. Notes Rec R Soc Lond (1998) 0.80
Traumatic wound rupture after penetrating keratoplasty in Africa. Br J Ophthalmol (1999) 0.80
The effect of topical steroid application on natural killer cell activity. Clin Exp Allergy (1989) 0.79
In vitro reaction of cancer patients and others to Bacillus Calmette-Gueérin. Int J Cancer (1980) 0.79
The contribution of direct immunofluorescence to the diagnosis of lupus erythematosus. J Cutan Pathol (1989) 0.79
Personal solar UV-A doses received by patients undergoing oral psoralen photochemotherapy for psoriasis. Br J Dermatol (1981) 0.79
The unexpected sites of melanoma regional recurrences. J Plast Reconstr Aesthet Surg (2006) 0.79
The in vitro lysozyme susceptibility of Candida albicans cultured in carbohydrate-supplemented media. Oral Microbiol Immunol (1993) 0.79
Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapy. Br J Dermatol (1994) 0.79
The role of sunlight in the aetiology of cutaneous malignant melanoma. Clin Exp Dermatol (1981) 0.79
A study of genetic linkage in schizophrenia. Psychol Med (1987) 0.79
Caries prevalence and microbiological and salivary caries activity tests in Scottish adolescents. Community Dent Oral Epidemiol (1990) 0.79
Keratinocyte expression of intercellular adhesion molecule 1 (ICAM-1) correlated with infiltration of lymphocyte function associated antigen 1 (LFA-1) positive cells in evolving allergic contact dermatitis reactions. Histopathology (1991) 0.79
Lionel Penrose, F.R.S. (1898-1972) and eugenics. Part two. Notes Rec R Soc Lond (1998) 0.79
Prediction of caries increment in Scottish adolescents. Community Dent Oral Epidemiol (1991) 0.79
Human melanoma cell-derived factor(s) stimulate fibroblast glycosaminoglycan synthesis. Int J Cancer (1992) 0.79
An examination of the immunology of cancer patients. Int J Cancer (1976) 0.79